位置:首页 > 蛋白库 > AT1A2_MOUSE
AT1A2_MOUSE
ID   AT1A2_MOUSE             Reviewed;        1020 AA.
AC   Q6PIE5; Q80UZ8;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 161.
DE   RecName: Full=Sodium/potassium-transporting ATPase subunit alpha-2;
DE            Short=Na(+)/K(+) ATPase alpha-2 subunit;
DE            EC=7.2.2.13;
DE   AltName: Full=Na(+)/K(+) ATPase alpha(+) subunit;
DE   AltName: Full=Sodium pump subunit alpha-2;
DE   Flags: Precursor;
GN   Name=Atp1a2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II, and FVB/N; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 44-59; 73-89; 161-171; 176-192; 211-238; 254-262;
RP   358-375; 413-428; 433-442; 444-456; 475-485; 494-505; 524-561; 565-602;
RP   610-622; 627-655; 659-680; 696-771; 891-908; 938-947 AND 1008-1016.
RC   STRAIN=C57BL/6J, and OF1; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Kang S.U., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-450; SER-559 AND
RP   SER-672, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Lung, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: This is the catalytic component of the active enzyme, which
CC       catalyzes the hydrolysis of ATP coupled with the exchange of sodium and
CC       potassium ions across the plasma membrane. This action creates the
CC       electrochemical gradient of sodium and potassium ions, providing the
CC       energy for active transport of various nutrients (By similarity).
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O + K(+)(out) + Na(+)(in) = ADP + H(+) + K(+)(in) +
CC         Na(+)(out) + phosphate; Xref=Rhea:RHEA:18353, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29101, ChEBI:CHEBI:29103,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216;
CC         EC=7.2.2.13;
CC   -!- SUBUNIT: The sodium/potassium-transporting ATPase is composed of a
CC       catalytic alpha subunit, an auxiliary non-catalytic beta subunit and an
CC       additional regulatory subunit. Interacts with regulatory subunit FXYD1.
CC       {ECO:0000250|UniProtKB:A2VDL6}.
CC   -!- INTERACTION:
CC       Q6PIE5; P11881: Itpr1; NbExp=3; IntAct=EBI-6665421, EBI-541478;
CC       Q6PIE5; O35157: Slc8a1; NbExp=4; IntAct=EBI-6665421, EBI-8351080;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}. Cell membrane {ECO:0000250}; Multi-pass membrane
CC       protein {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cation transport ATPase (P-type) (TC 3.A.3)
CC       family. Type IIC subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC036127; AAH36127.1; -; mRNA.
DR   EMBL; BC041774; AAH41774.1; -; mRNA.
DR   CCDS; CCDS35782.1; -.
DR   RefSeq; NP_848492.1; NM_178405.3.
DR   AlphaFoldDB; Q6PIE5; -.
DR   SMR; Q6PIE5; -.
DR   BioGRID; 221101; 13.
DR   DIP; DIP-48355N; -.
DR   IntAct; Q6PIE5; 8.
DR   MINT; Q6PIE5; -.
DR   STRING; 10090.ENSMUSP00000083077; -.
DR   GlyConnect; 2726; 1 N-Linked glycan (1 site).
DR   GlyGen; Q6PIE5; 1 site, 1 N-linked glycan (1 site).
DR   iPTMnet; Q6PIE5; -.
DR   PhosphoSitePlus; Q6PIE5; -.
DR   SwissPalm; Q6PIE5; -.
DR   jPOST; Q6PIE5; -.
DR   MaxQB; Q6PIE5; -.
DR   PaxDb; Q6PIE5; -.
DR   PeptideAtlas; Q6PIE5; -.
DR   PRIDE; Q6PIE5; -.
DR   ProteomicsDB; 281816; -.
DR   Antibodypedia; 34270; 170 antibodies from 27 providers.
DR   DNASU; 98660; -.
DR   Ensembl; ENSMUST00000085913; ENSMUSP00000083077; ENSMUSG00000007097.
DR   GeneID; 98660; -.
DR   KEGG; mmu:98660; -.
DR   UCSC; uc007dqc.1; mouse.
DR   CTD; 477; -.
DR   MGI; MGI:88106; Atp1a2.
DR   VEuPathDB; HostDB:ENSMUSG00000007097; -.
DR   eggNOG; KOG0203; Eukaryota.
DR   GeneTree; ENSGT00940000159936; -.
DR   HOGENOM; CLU_002360_4_1_1; -.
DR   InParanoid; Q6PIE5; -.
DR   OMA; RYCAMTG; -.
DR   OrthoDB; 388324at2759; -.
DR   PhylomeDB; Q6PIE5; -.
DR   TreeFam; TF312838; -.
DR   Reactome; R-MMU-5578775; Ion homeostasis.
DR   Reactome; R-MMU-936837; Ion transport by P-type ATPases.
DR   BioGRID-ORCS; 98660; 2 hits in 71 CRISPR screens.
DR   ChiTaRS; Atp1a2; mouse.
DR   PRO; PR:Q6PIE5; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q6PIE5; protein.
DR   Bgee; ENSMUSG00000007097; Expressed in ciliary body and 248 other tissues.
DR   ExpressionAtlas; Q6PIE5; baseline and differential.
DR   Genevisible; Q6PIE5; MM.
DR   GO; GO:0005901; C:caveola; ISO:MGI.
DR   GO; GO:0042995; C:cell projection; IDA:ARUK-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; ISO:MGI.
DR   GO; GO:0005768; C:endosome; ISO:MGI.
DR   GO; GO:0014704; C:intercalated disc; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISO:MGI.
DR   GO; GO:0043209; C:myelin sheath; HDA:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; ISO:MGI.
DR   GO; GO:0043025; C:neuronal cell body; IDA:ARUK-UCL.
DR   GO; GO:0031090; C:organelle membrane; ISO:MGI.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0042383; C:sarcolemma; IDA:BHF-UCL.
DR   GO; GO:0005890; C:sodium:potassium-exchanging ATPase complex; ISO:MGI.
DR   GO; GO:0045202; C:synapse; ISO:MGI.
DR   GO; GO:0030315; C:T-tubule; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; ISO:MGI.
DR   GO; GO:0016887; F:ATP hydrolysis activity; ISO:MGI.
DR   GO; GO:0019829; F:ATPase-coupled cation transmembrane transporter activity; ISO:MGI.
DR   GO; GO:0051087; F:chaperone binding; ISO:MGI.
DR   GO; GO:0005391; F:P-type sodium:potassium-exchanging transporter activity; ISS:UniProtKB.
DR   GO; GO:0030955; F:potassium ion binding; ISO:MGI.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISO:MGI.
DR   GO; GO:0031402; F:sodium ion binding; ISO:MGI.
DR   GO; GO:0005496; F:steroid binding; ISO:MGI.
DR   GO; GO:1990239; F:steroid hormone binding; ISO:MGI.
DR   GO; GO:0008344; P:adult locomotory behavior; IMP:MGI.
DR   GO; GO:0021764; P:amygdala development; IMP:ARUK-UCL.
DR   GO; GO:0046034; P:ATP metabolic process; ISO:MGI.
DR   GO; GO:0001662; P:behavioral fear response; IMP:ARUK-UCL.
DR   GO; GO:0098655; P:cation transmembrane transport; ISO:MGI.
DR   GO; GO:0030007; P:cellular potassium ion homeostasis; ISO:MGI.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISO:MGI.
DR   GO; GO:0071383; P:cellular response to steroid hormone stimulus; IDA:BHF-UCL.
DR   GO; GO:0006883; P:cellular sodium ion homeostasis; ISO:MGI.
DR   GO; GO:0040011; P:locomotion; IMP:MGI.
DR   GO; GO:0035641; P:locomotory exploration behavior; IMP:ARUK-UCL.
DR   GO; GO:1903170; P:negative regulation of calcium ion transmembrane transport; ISO:MGI.
DR   GO; GO:1903280; P:negative regulation of calcium:sodium antiporter activity; ISO:MGI.
DR   GO; GO:0051481; P:negative regulation of cytosolic calcium ion concentration; IMP:MGI.
DR   GO; GO:0045822; P:negative regulation of heart contraction; IMP:MGI.
DR   GO; GO:0045988; P:negative regulation of striated muscle contraction; IMP:MGI.
DR   GO; GO:0001504; P:neurotransmitter uptake; IMP:ARUK-UCL.
DR   GO; GO:0021989; P:olfactory cortex development; IMP:ARUK-UCL.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; ISO:MGI.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0006813; P:potassium ion transport; ISO:MGI.
DR   GO; GO:1902600; P:proton transmembrane transport; ISO:MGI.
DR   GO; GO:0008217; P:regulation of blood pressure; IGI:MGI.
DR   GO; GO:0086004; P:regulation of cardiac muscle cell contraction; ISO:MGI.
DR   GO; GO:0006937; P:regulation of muscle contraction; IMP:MGI.
DR   GO; GO:0002087; P:regulation of respiratory gaseous exchange by nervous system process; IMP:MGI.
DR   GO; GO:0006940; P:regulation of smooth muscle contraction; IMP:MGI.
DR   GO; GO:0006942; P:regulation of striated muscle contraction; IMP:MGI.
DR   GO; GO:0002026; P:regulation of the force of heart contraction; IMP:MGI.
DR   GO; GO:0019229; P:regulation of vasoconstriction; IMP:MGI.
DR   GO; GO:0010996; P:response to auditory stimulus; IMP:ARUK-UCL.
DR   GO; GO:1903416; P:response to glycoside; IMP:BHF-UCL.
DR   GO; GO:0035094; P:response to nicotine; ISO:MGI.
DR   GO; GO:0036376; P:sodium ion export across plasma membrane; ISO:MGI.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:MGI.
DR   GO; GO:0006814; P:sodium ion transport; ISO:MGI.
DR   GO; GO:0008542; P:visual learning; IMP:MGI.
DR   CDD; cd02608; P-type_ATPase_Na-K_like; 1.
DR   Gene3D; 3.40.1110.10; -; 1.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR006068; ATPase_P-typ_cation-transptr_C.
DR   InterPro; IPR004014; ATPase_P-typ_cation-transptr_N.
DR   InterPro; IPR023299; ATPase_P-typ_cyto_dom_N.
DR   InterPro; IPR018303; ATPase_P-typ_P_site.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR005775; P-type_ATPase_IIC.
DR   InterPro; IPR001757; P_typ_ATPase.
DR   InterPro; IPR044492; P_typ_ATPase_HD_dom.
DR   Pfam; PF00689; Cation_ATPase_C; 1.
DR   Pfam; PF00690; Cation_ATPase_N; 1.
DR   SFLD; SFLDF00027; p-type_atpase; 1.
DR   SMART; SM00831; Cation_ATPase_N; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   SUPFAM; SSF81653; SSF81653; 1.
DR   SUPFAM; SSF81660; SSF81660; 1.
DR   SUPFAM; SSF81665; SSF81665; 1.
DR   TIGRFAMs; TIGR01106; ATPase-IIC_X-K; 1.
DR   TIGRFAMs; TIGR01494; ATPase_P-type; 2.
DR   PROSITE; PS00154; ATPASE_E1_E2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell membrane; Direct protein sequencing; Ion transport;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Potassium; Potassium transport; Reference proteome; Sodium;
KW   Sodium transport; Sodium/potassium transport; Translocase; Transmembrane;
KW   Transmembrane helix; Transport.
FT   PROPEP          1..5
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000002505"
FT   CHAIN           6..1020
FT                   /note="Sodium/potassium-transporting ATPase subunit alpha-
FT                   2"
FT                   /id="PRO_0000002506"
FT   TOPO_DOM        6..85
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        86..106
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        107..129
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        130..150
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        151..286
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        287..306
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        307..318
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        319..336
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        337..769
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        770..789
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        790..799
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        800..820
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        821..840
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        841..863
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        864..915
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        916..935
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        936..948
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        949..967
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        968..982
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        983..1003
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1004..1020
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          80..82
FT                   /note="Interaction with phosphoinositide-3 kinase"
FT                   /evidence="ECO:0000250"
FT   REGION          212..231
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        212..230
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        374
FT                   /note="4-aspartylphosphate intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         714
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   BINDING         718
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06686"
FT   MOD_RES         450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P06686"
FT   MOD_RES         559
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         570
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P50993"
FT   MOD_RES         587
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P50993"
FT   MOD_RES         672
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         826
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09626"
FT   MOD_RES         940
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   1020 AA;  112217 MW;  5436E795BD5B4CFA CRC64;
     MGRGAGREYS PAATTAENGG GKKKQKEKEL DELKKEVAMD DHKLSLDELG RKYQVDLSKG
     LTNQRAQDIL ARDGPNALTP PPTTPEWVKF CRQLFGGFSI LLWIGALLCF LAYGILAAME
     DEPSNDNLYL GIVLAAVVIV TGCFSYYQEA KSSKIMDSFK NMVPQQALVI REGEKMQINA
     EEVVVGDLVE VKGGDRVPAD LRIISSHGCK VDNSSLTGES EPQTRSPEFT HENPLETRNI
     CFFSTNCVEG TARGIVIATG DRTVMGRIAT LASGLEVGQT PIAMEIEHFI QLITGVAVFL
     GVSFFVLSLI LGYSWLEAVI FLIGIIVANV PEGLLATVTV CLTLTAKRMA RKNCLVKNLE
     AVETLGSTST ICSDKTGTLT QNRMTVAHMW FDNQIHEADT TEDQSGATFD KRSPTWTALS
     RIAGLCNRAV FKAGQENISV SKRDTAGDAS ESALLKCIEL SCGSVRKMRD RNPKVAEIPF
     NSTNKYQLSI HEREDSPQSH VLVMKGAPER ILDRCSTILV QGKEIPLDKE MQDAFQNAYM
     ELGGLGERVL GFCQLNLPSG KFPRGFKFDT DELNFPTEKL CFVGLMSMID PPRAAVPDAV
     GKCRSAGIKV IMVTGDHPIT AKAIAKGVGI ISEGNETVED IAARLNIPVS QVNPREAKAC
     VVHGSDLKDM TSEQLDEILR DHTEIVFART SPQQKLIIVE GCQRQGAIVA VTGDGVNDSP
     ALKKADIGIA MGISGSDVSK QAADMILLDD NFASIVTGVE EGRLIFDNLK KSIAYTLTSN
     IPEITPFLLF IIANIPLPLG TVTILCIDLG TDMVPAISLA YEAAESDIMK RQPRNSQTDK
     LVNERLISMA YGQIGMIQAL GGFFTYFVIL AENGFLPSRL LGIRLDWDDR TTNDLEDSYG
     QEWTYEQRKV VEFTCHTAFF ASIVVVQWAD LIICKTRRNS VFQQGMKNKI LIFGLLEETA
     LAAFLSYCPG MGVALRMYPL KVTWWFCAFP YSLLIFIYDE VRKLILRRYP GGWVEKETYY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024